← Back to Search

Implant

MINIject™ Implant for Glaucoma (STAR-V Trial)

N/A
Recruiting
Research Sponsored by iSTAR Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Males and females, 46 years of age or older
A diagnosis of primary open-angle glaucoma, who are candidates for medical therapy, laser treatment, or glaucoma-filtering surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

STAR-V Trial Summary

This trial will test a new implant to see if it is safe and effective at lowering eye pressure in people with glaucoma.

Who is the study for?
This trial is for men and women aged 46 or older with primary open-angle glaucoma who have had successful cataract surgery. It's suitable for those needing medical therapy, laser treatment, or surgery for glaucoma. People with eye inflammation, infections, degenerative visual disorders, or other types of glaucoma cannot participate.Check my eligibility
What is being tested?
The MINIject™ Implant by iSTAR Medical is being tested to see if it can safely lower intraocular pressure in patients with primary open-angle glaucoma. The study aims to evaluate its effectiveness compared to standard treatments.See study design
What are the potential side effects?
Potential side effects may include discomfort at the implant site, increased eye pressure requiring additional treatment, infection risk post-surgery, and possible changes in vision.

STAR-V Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 46 years old or older.
Select...
I have primary open-angle glaucoma and can undergo treatment or surgery.
Select...
I'm sorry, but "Key" is not a screening criterion. It is not possible to provide a summary or rewrite without additional context. Please provide more information.
Select...
I have had successful cataract surgery and now have an artificial lens.

STAR-V Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intraocular pressure decrease
Intraocular pressure decrease (outcome 2)

STAR-V Trial Design

1Treatment groups
Experimental Treatment
Group I: Implant GroupExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

iSTAR MedicalLead Sponsor
10 Previous Clinical Trials
1,345 Total Patients Enrolled
10 Trials studying Glaucoma
1,345 Patients Enrolled for Glaucoma
Abhi Vilupuru, Ph.DStudy ChairiSTAR Medical

Media Library

MINIject™ Implant (Implant) Clinical Trial Eligibility Overview. Trial Name: NCT05024695 — N/A
Glaucoma Research Study Groups: Implant Group
Glaucoma Clinical Trial 2023: MINIject™ Implant Highlights & Side Effects. Trial Name: NCT05024695 — N/A
MINIject™ Implant (Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05024695 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently seeking volunteers for this project?

"Correct. According to the data hosted on clinicaltrials.gov, this experiment is actively recruiting patients after being posted on August 19th 2021 and updated most recently on August 23rd 2021. It aims to enroll 975 individuals at a single medical centre."

Answered by AI

How many participants are involved in this research?

"Indeed, the details uploaded to clinicaltrials.gov highlight that this research project is actively searching for recruits. The trial was unveiled on August 19th 2021 and its information has been adjusted as recently as August 23rd 2021; it aims to enlist 975 people from a single medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Texas
West Virginia
District of Columbia
How old are they?
18 - 65
What site did they apply to?
Vold Vision
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.
2021. "Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05024695.
All > Intraocular Lens > Glaucoma
~232 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top